Dosing 5-ASA for Ulcerative Colitis: Is the Maximum Optimum?
Crossref DOI link: https://doi.org/10.1007/s10620-026-09874-x
Published Online: 2026-04-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Nai-Yu
Chuang, Chiao-Hsiung
Text and Data Mining valid from 2026-04-02
Version of Record valid from 2026-04-02
Article History
Received: 5 March 2026
Accepted: 25 March 2026
First Online: 2 April 2026
Declarations
:
: The authors declare no conflicts of interest.
Free to read: This content has been made available to all.